Black B S, Gher M E, Sandifer J B, Fucini S E, Richardson A C
Periodontics Department, Naval Dental School, National Naval Dental Center, Bethesda, MD.
J Periodontol. 1994 Jun;65(6):598-604. doi: 10.1902/jop.1994.65.6.598.
The purpose of this study was to compare the changes in clinical attachment when either a non-resorbable ePTFE membrane or an absorbable collagen membrane was used as a barrier during surgical treatment of class II molar furcation defects. Thirteen patients, mean age 43.2 years, with two comparable class II molar defects were treated using a split mouth design. Pre-surgical standardized probings were made using an automated probe at a constant force of 25 grams. Four to 6 weeks after initial therapy, the furcations were surgically debrided, the membranes placed to occlude separate furcation defects in each patient, and the sites closed. The ePTFE membrane was removed 6 weeks after placement. Six months postsurgery, the clinical measurements were repeated. Student t test was used to compare the results. There were no significant differences in the mean initial measurements between the treatment groups. The mean decrease in vertical probing depth was 1.40 +/- 1.68 mm for the collagen treated sites and 1.07 +/- 0.81 mm for the ePTFE treated sites. The decrease in horizontal probing depth was 1.49 +/- 1.97 mm for the collagen treated sites and 0.79 +/- 2.16 mm for the ePTFE treated sites. No significant differences were found between any of the clinical parameters measured. Based on the results of this short-term clinical study, the absorbable collagen membrane was statistically equivalent to the non-resorbable ePTFE membrane in the clinical resolution of class II furcation defects.
本研究的目的是比较在II类磨牙根分叉病变的外科治疗中,使用不可吸收的ePTFE膜或可吸收的胶原膜作为屏障时临床附着的变化。采用双侧对照设计,对13例平均年龄43.2岁、患有两个可比较的II类磨牙根分叉病变的患者进行治疗。术前使用自动探针以25克的恒定力进行标准化探诊。初始治疗后4至6周,对根分叉进行手术清创,在每位患者中放置膜以封闭单独的根分叉病变,然后缝合创口。ePTFE膜在放置6周后取出。术后6个月,重复进行临床测量。采用学生t检验比较结果。治疗组之间的平均初始测量值无显著差异。胶原膜治疗部位的垂直探诊深度平均减少1.40±1.68毫米,ePTFE膜治疗部位为1.07±0.81毫米。胶原膜治疗部位的水平探诊深度减少1.49±1.97毫米,ePTFE膜治疗部位为0.79±2.16毫米。在所测量的任何临床参数之间均未发现显著差异。基于这项短期临床研究的结果,在II类根分叉病变的临床治疗效果上,可吸收的胶原膜在统计学上等同于不可吸收的ePTFE膜。